DDL logo
Menu
  • The Aerosol Society logo
DDL logo
  • DDL2023
    • Call for Papers
    • Sponsor and Exhibit
    • New Researcher Network
    • Conference Logistics
    • Media Partners
  • Archive
    • Conference Papers Archive
    • DDL2022
      • APS Workshop
      • Conference Papers
      • DDL2022 Programme
      • DDL2022 Speakers
      • DDL2022 Sponsors
      • DDL2022 Photo Album
    • DDL2021
      • Conference Papers
      • DDL2021 Programme
      • DDL2021 Speakers
      • DDL2021 Sponsors
    • DDL2020
      • Conference Papers
      • Speakers and Lecture Recordings
      • Sponsors
    • DDL2019
      • Conference Papers
      • Speakers
      • Sponsors
      • DDL2019 Photo Album
    • DDL2018
      • Conference Papers
      • Speakers
      • Sponsors
      • DDL2018 Photo Album
    • DDL2017
      • Conference Papers
      • Speakers
      • Sponsors
      • DDL2017 Photo Album
    • DDL2016
      • Conference Papers
      • Speakers
      • Sponsors
    • DDL2015
      • Conference Papers
    • Previous Years
  • DDL Annual Lecture
  • Awards & Grants
    • DDL Career Development Grant
    • The DDL Emerging Scientist Award
    • The Pat Burnell Young Investigator Award
    • Aerosol Society Awards
  • About
    • Gallery
    • History
    • DDL Charter
    • Committee
    • Scientific Advisors
  • Associated Events
    • EPSRC CDT in Aerosol Science Annual Conference 2023
    • ERS International Congress 2023
    • ISAM Congress 2023
    • RDD Europe 2023
  • Contact
  • The Aerosol Society logo
Claire Dumont :

Claire Dumont

Research Assistant

Paper: Development of airways protection against respiratory Nipah virus infection by inhalation of antiviral peptides

Claire Dumont is a research assistant in the laboratory of Dr. Branka Horvat (International Center for Infectiology Reseach-CIRI, Lyon, France). Originally from Tours, where she obtained a master degree in Vaccinology/Infectiology, she spent 2 years in Australia as research assistant in laboratory of Drs. Villadangos and Mintern (Bio21 Institute, Melbourne AUS), working in the immunology field. She joined CIRI (INSERM-U1111, Lyon FRANCE) in 2017 where she participates in the study of measles and Nipah virus immunopathogenesis, using level 2 and 4 biosafety laboratories and animal experimentation. She is implicated in the development of new anti-viral approach against paramyxoviruses, based on peptide-mediated inhibition of virus-cell fusion.

Video of Claire Dumont

  • Terms
  • Privacy & Cookie policy
  • Contact
  • Committee

© 2023 Drug Delivery to the Lungs Website design: definingdesign.co.uk